The WHO has a more active role to play in promoting sustainable innovation that would be more responsive to public health needs
Nearly 2 billion people have no access to basic medicines. High prices of medicines linked to current patent-centred and market-driven model of R&D, challenge implementing Agenda 2030, guided by the principle “leave none behind”. Alternative innovation models based on “de-linking” costs of R&D and prices of the medicines need to evolve in order to improve …
